person · Reporting owner

MCFARLAND KATHARINA G.

Disclosed activity across 4 companies

Tapewire entity: 41238
SEC CIK: 0001711062

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Science Applications International CorpSAIC · Entity 3870	Director	June 03, 2026	June 04, 2026
Virgin Orbit Holdings, Inc.VORB · Entity 114569	Director	August 30, 2022	September 01, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Science Applications International Corp

Report date June 03, 2026 · Filed June 04, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	10,624	Reported balance After 2026-06-03 transaction · row 1 1 source row Row 1 · 2026-06-03 · Grant · Acquired 1,886 · Balance 10,624

Virgin Orbit Holdings, Inc.

Report date August 30, 2022 · Filed September 01, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common stockSEC Table I · non-derivative	Direct	39,979	Reported balance After 2022-08-30 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2022-08-30 · Grant · Acquired 28,986 · Balance 39,979 F1: Represents an award of restricted stock units, which shall vest in full on the earlier of the one-year anniversary of August 30, 2022, or the date of the next Annual Meeting in 2023, subject to continued service through applicable vesting date. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting.
Common stockSEC Table I · non-derivative	Direct	10,993	Reported balance Holding disclosure · report date 2022-08-30 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 10,993

Filing footnotes · ownership attribution and instrument terms

F1: Represents an award of restricted stock units, which shall vest in full on the earlier of the one-year anniversary of August 30, 2022, or the date of the next Annual Meeting in 2023, subject to continued service through applicable vesting date. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Engility Holdings, Inc.

Report date January 14, 2019 · Filed January 14, 2019

Section 16 reporting ended · disclosed 2019-01-14. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-01-14 transaction · row 1 1 source row Row 1 · 2019-01-14 · Disposition to issuer · Disposed 7,199 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 9, 2018, among Engility Holdings, Inc. (the "Company"), Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, each share of the Company's common stock owned by the reporting person immediately prior to the effective time (the "Effective Time") of the merger of Merger Sub with and into the Company (the "merger"), with the Company surviving the merger as a wholly owned subsidiary of SAIC, was, upon the Effective Time, converted into the right to receive 0.450 shares of common stock of SAIC, with cash in lieu of fractional shares.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 9, 2018, among Engility Holdings, Inc. (the "Company"), Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, each share of the Company's common stock owned by the reporting person immediately prior to the effective time (the "Effective Time") of the merger of Merger Sub with and into the Company (the "merger"), with the Company surviving the merger as a wholly owned subsidiary of SAIC, was, upon the Effective Time, converted into the right to receive 0.450 shares of common stock of SAIC, with cash in lieu of fractional shares.

Transphorm, Inc.

Report date June 20, 2024 · Filed June 20, 2024

Section 16 reporting ended · disclosed 2024-06-20. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2024-06-20 transaction · row 1 1 source row Row 1 · 2024-06-20 · Disposition to issuer · Disposed 81,323 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 10, 2024, by and among Transphorm, Inc. (the "Issuer"), Renesas Electronics America Inc. ("Parent"), Travis Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Renesas Electronics Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F2: At the effective time of the Merger, outstanding shares were automatically converted solely into the right to receive an amount in cash, without interest, equal to $5.10 per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement. F3: Certain of these securities are represented by Restricted Stock Units ("RSUs"). Vested RSUs (taking into account any applicable vesting acceleration in connection with the Merger) were cancelled and converted into the right to receive an amount in cash equal to, for each share of Common Stock subject to such vested RSUs, the Per Share Price.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.50 · Expires 2031-02-23	Direct	0	Reported balance After 2024-06-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2024-06-20 · Disposition to issuer · Disposed 55,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 10, 2024, by and among Transphorm, Inc. (the "Issuer"), Renesas Electronics America Inc. ("Parent"), Travis Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Renesas Electronics Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F4: At the effective time of the Merger, this stock option had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, was cancelled for no consideration or payment.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 10, 2024, by and among Transphorm, Inc. (the "Issuer"), Renesas Electronics America Inc. ("Parent"), Travis Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Renesas Electronics Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent.

F2: At the effective time of the Merger, outstanding shares were automatically converted solely into the right to receive an amount in cash, without interest, equal to $5.10 per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement.

F3: Certain of these securities are represented by Restricted Stock Units ("RSUs"). Vested RSUs (taking into account any applicable vesting acceleration in connection with the Merger) were cancelled and converted into the right to receive an amount in cash equal to, for each share of Common Stock subject to such vested RSUs, the Per Share Price.

F4: At the effective time of the Merger, this stock option had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, was cancelled for no consideration or payment.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 03, 2026 Filed Jun 4, 2026 20:11 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,886	$0.00	$0.00	Disclosure SEC source: 0001571123-26-000099 · wk-form4_1780603869.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,624 Read SEC document
June 04, 2025 Filed Jun 5, 2025 20:33 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,644	$103.43	$170,038.92	Disclosure SEC source: 0001571123-25-000129 · wk-form4_1749155432.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,738 Read SEC document
March 27, 2025 Filed Mar 28, 2025 20:01 UTC	Science Applications International Corp SAIC · Entity 3870	PurchaseCommon Stock	230	$109.86	$25,267.80	Disclosure SEC source: 0001571123-25-000042 · wk-form4_1743192068.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,094 F1 · kind: The reporting persons purchase of SAIC common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 230 shares, with the reporting persons sale of 230 shares of SAIC common stock at a price of $117.70 per share on January 13, 2025. The reporting person has agreed to pay to SAIC, upon settlement of the purchase, $1,803.20, representing the full amount of the profit realized in connection with the short-swing transaction. Read SEC document
January 13, 2025 Filed Jan 13, 2025 21:14 UTC	Science Applications International Corp SAIC · Entity 3870	SaleCommon Stock	3,239	$117.70	$381,230.30	Disclosure SEC source: 0001571123-25-000004 · wk-form4_1736802845.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,864 Read SEC document
June 20, 2024 Filed Jun 20, 2024 16:05 UTC	Transphorm, Inc. TGAN · Entity 15192	Disposition to issuerStock Option (right to buy) · Derivative	55,000	$0.00 Strike: $6.50	$0.00	Disclosure SEC source: 0001415889-24-017604 · form4-06202024_040606.xml · derivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2031-02-23 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 10, 2024, by and among Transphorm, Inc. (the "Issuer"), Renesas Electronics America Inc. ("Parent"), Travis Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Renesas Electronics Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F4 · derivative.exercise_date: At the effective time of the Merger, this stock option had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, was cancelled for no consideration or payment. Read SEC document
June 20, 2024 Filed Jun 20, 2024 16:05 UTC	Transphorm, Inc. TGAN · Entity 15192	Disposition to issuerCommon Stock	81,323	Not disclosed	Not disclosed	Disclosure SEC source: 0001415889-24-017604 · form4-06202024_040606.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 10, 2024, by and among Transphorm, Inc. (the "Issuer"), Renesas Electronics America Inc. ("Parent"), Travis Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and Renesas Electronics Corporation, Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger and becoming a wholly owned subsidiary of Parent. F2 · price: At the effective time of the Merger, outstanding shares were automatically converted solely into the right to receive an amount in cash, without interest, equal to $5.10 per share (the "Per Share Price"), subject to the terms and conditions of the Merger Agreement. F3 · price: Certain of these securities are represented by Restricted Stock Units ("RSUs"). Vested RSUs (taking into account any applicable vesting acceleration in connection with the Merger) were cancelled and converted into the right to receive an amount in cash equal to, for each share of Common Stock subject to such vested RSUs, the Per Share Price. Read SEC document
June 05, 2024 Filed Jun 6, 2024 20:04 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,451	$0.00	$0.00	Disclosure SEC source: 0001571123-24-000094 · wk-form4_1717704234.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,104 Read SEC document
May 22, 2024 Filed May 24, 2024 16:15 UTC	Transphorm, Inc. TGAN · Entity 15192	SaleCommon Stock	3,996	$4.89	$19,548.43	Disclosure SEC source: 0001415889-24-014470 · form4-05242024_040522.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,323 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2023. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $4.89 to $4.90 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
April 24, 2024 Filed Apr 26, 2024 16:05 UTC	Transphorm, Inc. TGAN · Entity 15192	SaleCommon Stock	840	$4.85	$4,074.00	Disclosure SEC source: 0001415889-24-011578 · form4-04262024_040404.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,319 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2023. Read SEC document
April 20, 2024 Filed Apr 23, 2024 16:44 UTC	Transphorm, Inc. TGAN · Entity 15192	GrantCommon Stock	2,400	$0.00	$0.00	Disclosure SEC source: 0001415889-24-011374 · form4-04232024_080423.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,159 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") that was fully vested as of the grant date. The RSUs were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended March 31, 2024. Read SEC document
April 12, 2024 Filed Apr 12, 2024 20:06 UTC	Science Applications International Corp SAIC · Entity 3870	SaleCommon Stock	760	$125.64	$95,486.40	Disclosure SEC source: 0001571123-24-000062 · wk-form4_1712952401.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,653 Read SEC document
February 28, 2024 Filed Mar 1, 2024 16:05 UTC	Transphorm, Inc. TGAN · Entity 15192	SaleCommon Stock	3,996	$4.81	$19,224.76	Disclosure SEC source: 0001415889-24-006072 · form4-03012024_040313.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,759 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2023. Read SEC document
January 24, 2024 Filed Jan 26, 2024 16:03 UTC	Transphorm, Inc. TGAN · Entity 15192	SaleCommon Stock	833	$4.82	$4,015.06	Disclosure SEC source: 0001209191-24-002294 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,755 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2023. Read SEC document
January 20, 2024 Filed Jan 23, 2024 16:34 UTC	Transphorm, Inc. TGAN · Entity 15192	GrantCommon Stock	2,380	$0.00	$0.00	Disclosure SEC source: 0001209191-24-002056 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,588 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") that was fully vested as of the grant date. The RSUs were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended December 31, 2023. Read SEC document
November 22, 2023 Filed Nov 27, 2023 20:23 UTC	Transphorm, Inc. TGAN · Entity 15192	SaleCommon Stock	3,995	$2.70	$10,798.49	Disclosure SEC source: 0001209191-23-056730 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,208 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2023. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $2.70 to $2.76 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
November 20, 2023 Filed Nov 21, 2023 16:34 UTC	Transphorm, Inc. TGAN · Entity 15192	SaleCommon Stock	3,515	$3.01	$10,580.15	Disclosure SEC source: 0001209191-23-056281 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,203 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2023. F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $3.00 to $3.025 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document
October 20, 2023 Filed Oct 24, 2023 16:14 UTC	Transphorm, Inc. TGAN · Entity 15192	GrantCommon Stock	4,791	$0.00	$0.00	Disclosure SEC source: 0001209191-23-053452 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,718 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU") that was fully vested as of the grant date. The RSUs were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended September 30, 2023. Read SEC document
October 11, 2023 Filed Oct 13, 2023 16:23 UTC	Transphorm, Inc. TGAN · Entity 15192	GrantCommon Stock	5,251	$0.00	$0.00	Disclosure SEC source: 0001209191-23-052772 · doc4.xml · nonDerivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,927 F2 · shares: Each share is represented by an RSU. The RSUs were fully vested as of the grant date. The shares were automatically granted to the Reporting Person pursuant to the Issuer's Outside Director Compensation Policy in lieu of cash fees for service during the quarter ended June 30, 2023. Read SEC document
October 11, 2023 Filed Oct 13, 2023 16:23 UTC	Transphorm, Inc. TGAN · Entity 15192	GrantCommon Stock	45,662	$0.00	$0.00	Disclosure SEC source: 0001209191-23-052772 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,676 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). One-fourth (1/4) of the RSUs will vest on each of November 20, 2023, February 20, 2024, May 20, 2024 and the earlier of August 20, 2024 or the day prior to the date of Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document
July 21, 2023 Filed Jul 25, 2023 18:29 UTC	Transphorm, Inc. TGAN · Entity 15192	Exercise / conversionSubscription Rights (right to buy) · Derivative	19,687	$0.00 Strike: $3.30	$0.00	Disclosure SEC source: 0001209191-23-043343 · doc4.xml · derivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,014 shares Expires 2023-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 21, 2023 Filed Jul 25, 2023 18:29 UTC	Transphorm, Inc. TGAN · Entity 15192	Exercise / conversionCommon Stock	3,014	$3.30	$9,946.20	Disclosure SEC source: 0001209191-23-043343 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents Issuer common stock acquired by the reporting person following the exercise of non-transferable subscription rights distributed in connection with the Issuer's rights offering to stockholders of record on June 26, 2023, as described in the Issuer's prospectus supplement dated July 5, 2023 and the accompanying base prospectus. Read SEC document
June 07, 2023 Filed Jun 8, 2023 20:24 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,600	$0.00	$0.00	Disclosure SEC source: 0001571123-23-000091 · wk-form4_1686255880.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,413 Read SEC document
April 13, 2023 Filed Apr 14, 2023 20:08 UTC	Science Applications International Corp SAIC · Entity 3870	SaleCommon Stock	1,193	$108.48	$129,417.71	Disclosure SEC source: 0001571123-23-000054 · wf-form4_168150290906610.xml · nonDerivative · entry 3 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,813 F1 · price: Weighted average of sales prices. Actual prices range from $108.44 to $108.53. Information regarding the number of shares sold at each separate price will be provided upon request. Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:08 UTC	Science Applications International Corp SAIC · Entity 3870	Exercise / conversionStock Option (Right to Buy) · Derivative	4,313	$0.00 Strike: $77.65	$0.00	Disclosure SEC source: 0001571123-23-000054 · wf-form4_168150290906610.xml · derivative · entry 4 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,313 shares Expires 2026-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:08 UTC	Science Applications International Corp SAIC · Entity 3870	Tax withholdingCommon Stock	3,120	$107.36	$334,963.20	Disclosure SEC source: 0001571123-23-000054 · wf-form4_168150290906610.xml · nonDerivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,006 Read SEC document
April 12, 2023 Filed Apr 14, 2023 20:08 UTC	Science Applications International Corp SAIC · Entity 3870	Exercise / conversionCommon Stock	4,313	$77.65	$334,904.45	Disclosure SEC source: 0001571123-23-000054 · wf-form4_168150290906610.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 30, 2022 Filed Sep 1, 2022 23:12 UTC	Virgin Orbit Holdings, Inc. VORB · Entity 114569	GrantCommon stock	28,986	$0.00	$0.00	Disclosure SEC source: 0001843388-22-000044 · wf-form4_166207391019758.xml · nonDerivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,979 F1 · shares: Represents an award of restricted stock units, which shall vest in full on the earlier of the one-year anniversary of August 30, 2022, or the date of the next Annual Meeting in 2023, subject to continued service through applicable vesting date. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting. Read SEC document
July 11, 2022 Filed Jul 11, 2022 20:02 UTC	Science Applications International Corp SAIC · Entity 3870	SaleCommon Stock	2,600	$93.30	$242,587.02	Disclosure SEC source: 0001571123-22-000053 · wf-form4_165756974774525.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,813 F1 · price: Weighted average of sales prices. Actual prices range from $93.18 to $93.42. Information regarding the number of shares sold at each separate price will be provided upon request. Read SEC document
June 15, 2022 Filed Jun 16, 2022 20:42 UTC	Virgin Orbit Holdings, Inc. VORB · Entity 114569	PurchaseCommon stock	2,884	$2.90	$8,363.60	Disclosure SEC source: 0001628280-22-017372 · wf-form4_165541210137729.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,993 Read SEC document
June 08, 2022 Filed Jun 9, 2022 20:05 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,742	$0.00	$0.00	Disclosure SEC source: 0001571123-22-000036 · wf-form4_165480512000363.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,413 Read SEC document
April 11, 2022 Filed May 6, 2022 01:36 UTC	Virgin Orbit Holdings, Inc. VORB · Entity 114569	GrantCommon stock	8,109	$0.00	$0.00	Disclosure SEC source: 0001628280-22-012811 · wf-form4_165180098359699.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,109 F1 · shares: Represents an award of restricted stock units, which vests as to one-third of the shares subject to the award on each anniversary of December 29, 2021 (the closing date of the Issuer's SPAC Merger), subject to continued service through applicable vesting date. The restricted stock units will be settled in shares of the Issuer's common stock upon vesting. Read SEC document
June 02, 2021 Filed Jun 3, 2021 20:03 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,765	$0.00	$0.00	Disclosure SEC source: 0001225208-21-008881 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,671 Read SEC document
February 23, 2021 Filed Feb 25, 2021 16:09 UTC	Transphorm, Inc. TGAN · Entity 15192	GrantStock Option (right to buy) · Derivative	55,000	$0.00 Strike: $6.50	$0.00	Disclosure SEC source: 0001209191-21-014290 · doc4.xml · derivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2031-02-23 F2 · derivative.exercise_date: One-fourth (1/4) of the shares subject to the option will vest on February 23, 2022, and the remaining shares will vest in equal quarterly installments over the following three years, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document
February 23, 2021 Filed Feb 25, 2021 16:09 UTC	Transphorm, Inc. TGAN · Entity 15192	GrantCommon Stock	35,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-014290 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). One-fourth (1/4) of the RSUs will vest on February 23, 2022, and the remaining shares will vest in equal quarterly installments over the following three years, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document
June 03, 2020 Filed Jun 4, 2020 20:02 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,734	$0.00	$0.00	Disclosure SEC source: 0001225208-20-008634 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,906 Read SEC document
June 05, 2019 Filed Jun 6, 2019 20:09 UTC	Science Applications International Corp SAIC · Entity 3870	GrantStock Option (Right to Buy) · Derivative	4,313	$0.00 Strike: $77.65	$0.00	Disclosure SEC source: 0001225208-19-008961 · doc4.xml · derivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,313 Underlying: Common Stock · 4,313 shares Expires 2026-06-04 F1 · derivative.exercise_date: The option may be exercised as to 100% of the option shares on or after the earlier of: (i) the first-year anniversary of the grant date or (ii) the date the annual meeting of stockholders of the Company following the grant date is concluded. Read SEC document
June 05, 2019 Filed Jun 6, 2019 20:09 UTC	Science Applications International Corp SAIC · Entity 3870	GrantCommon Stock	1,932	$0.00	$0.00	Disclosure SEC source: 0001225208-19-008961 · doc4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,172 Read SEC document
January 14, 2019 Filed Jan 14, 2019 20:58 UTC	Engility Holdings, Inc. EGL · Entity 16034	Disposition to issuerCommon Stock	7,199	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-19-001063 · form4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 9, 2018, among Engility Holdings, Inc. (the "Company"), Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, each share of the Company's common stock owned by the reporting person immediately prior to the effective time (the "Effective Time") of the merger of Merger Sub with and into the Company (the "merger"), with the Company surviving the merger as a wholly owned subsidiary of SAIC, was, upon the Effective Time, converted into the right to receive 0.450 shares of common stock of SAIC, with cash in lieu of fractional shares. Read SEC document
January 11, 2019 Filed Jan 14, 2019 20:20 UTC	Engility Holdings, Inc. EGL · Entity 16034	Exercise / conversionRestricted Stock Units · Derivative	3,228	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-19-001039 · form4.xml · derivative · entry 4 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · derivative.exercise_price: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. F1 · price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · price: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. F1 · derivative.exercise_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · derivative.exercise_date: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. F1 · derivative.expiration_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · derivative.expiration_date: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. Read SEC document
January 11, 2019 Filed Jan 14, 2019 20:20 UTC	Engility Holdings, Inc. EGL · Entity 16034	Exercise / conversionRestricted Stock Units · Derivative	3,971	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-19-001039 · form4.xml · derivative · entry 3 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,971 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · derivative.exercise_price: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. F1 · price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · price: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. F1 · derivative.exercise_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · derivative.exercise_date: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. F1 · derivative.expiration_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · derivative.expiration_date: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. Read SEC document
January 11, 2019 Filed Jan 14, 2019 20:20 UTC	Engility Holdings, Inc. EGL · Entity 16034	Exercise / conversionCommon Stock	3,228	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-19-001039 · form4.xml · nonDerivative · entry 2 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · price: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. Read SEC document
January 11, 2019 Filed Jan 14, 2019 20:20 UTC	Engility Holdings, Inc. EGL · Entity 16034	Exercise / conversionCommon Stock	3,971	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-19-001039 · form4.xml · nonDerivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of common stock ("Common Stock") of Engility Holdings, Inc. (the "Company") or (at the discretion of the Compensation Committee of the Company) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of the Company or (ii) a change of control of the Company. F2 · price: The Board of Directors and Compensation Committee of the Company have elected, pursuant to the pending merger (as defined below) under the Agreement and Plan of Merger, dated as of September 9, 2018, among the Company, Science Applications International Corporation ("SAIC") and Raptors Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of SAIC, with the Company surviving the merger of Merger Sub with and into the Company (the "merger") as a wholly owned subsidiary of SAIC, to accelerate the vesting of all RSUs held by the Reporting Person and settle all vested, but undelivered, RSUs in Common Stock effective January 11, 2019. Read SEC document
May 24, 2018 Filed May 29, 2018 19:32 UTC	Engility Holdings, Inc. EGL · Entity 16034	GrantRestricted Stock Units · Derivative	3,971	$0.00	$0.00	Disclosure SEC source: 0001127602-18-019154 · form4.xml · derivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,971 Underlying: Common Stock · 3,971 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of Common Stock or (at the discretion of the Compensation Committee) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of Engility Holdings, Inc. (the "Issuer") or (ii) a change of control of the Issuer. F1 · derivative.exercise_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of Common Stock or (at the discretion of the Compensation Committee) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of Engility Holdings, Inc. (the "Issuer") or (ii) a change of control of the Issuer. F1 · derivative.expiration_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of Common Stock or (at the discretion of the Compensation Committee) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of Engility Holdings, Inc. (the "Issuer") or (ii) a change of control of the Issuer. Read SEC document
July 07, 2017 Filed Jul 7, 2017 11:05 UTC	Engility Holdings, Inc. EGL · Entity 16034	GrantRestricted Stock Units · Derivative	3,228	$0.00	$0.00	Disclosure SEC source: 0001127602-17-023343 · form4.xml · derivative · entry 1 MCFARLAND KATHARINA G. · CIK 0001711062 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,228 Underlying: Common Stock · 3,228 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of Common Stock or (at the discretion of the Compensation Committee) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of Engility Holdings, Inc. (the "Issuer") or (ii) a change of control of the Issuer. F1 · shares: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of Common Stock or (at the discretion of the Compensation Committee) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of Engility Holdings, Inc. (the "Issuer") or (ii) a change of control of the Issuer. F1 · derivative.exercise_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of Common Stock or (at the discretion of the Compensation Committee) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of Engility Holdings, Inc. (the "Issuer") or (ii) a change of control of the Issuer. F1 · derivative.expiration_date: Grant of restricted stock units ("RSUs") that vest on the one-year anniversary of the grant date. Vested RSUs do not convert into shares of Common Stock or (at the discretion of the Compensation Committee) cash until the earlier of (i) the date on which the Reporting Person ceases to be a director of Engility Holdings, Inc. (the "Issuer") or (ii) a change of control of the Issuer. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.